l-carnitine cas number Acetyl-L-Carnitine and endurance C2) Acetylcarnitine | CAS#:14992-62-2 (inner

8 Advantages and realistic prospects of drug repurposing in AD As already mentioned in section 6, drug repurposing represents the strategic identification of new therapeutic uses for existing approved or investigational drugs (Recino et al., 2025)

Missense Common mutation: Glu474Gln Reduces LCHAD activity Homozygous clinical: Neonatal death Allelic disorders Trifunctional Protein Nosology: Trifunctional protein, subunit Functions Catalyzes steps in long-chain intra-mitochondrial -oxidation Source of energy: Skeletal muscle & Heart MTP deficiency also caused by mutations in: HADHB MTP components Heterooctameric HADHA (LCHAD & LCEH enzymes) HADHB (LCKAT enzyme) Location: Inner mitochondrial membrane Common defect in MTP: LCHAD See: Lipid disorders Clinical: Several syndromes HADHA variant: Infant syndrome Clinical Onset: 1st 2 years Cardiomyopathy Muscle: Hypotonia Hepatomegaly Retinopathy: Pigmentary Course Recurrent metabolic crises, or Steadily progressive Death Arms

Insulin appears to assist muscle carnitine uptake, which is why several trials paired the dose with carbohydrate

Conversely, USP2 functions as a negative regulator of clockophagy-induced ferroptosis